The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract infections (uUTIs) in women and young girls, in a first approval of its kind in nearly 30 years.

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug approved in decades and the first in a new class of medications. British

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the standard antibiotics.